All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
XPH real return snapshot: after CPI-U inflation, XPH returned +26.33% over the past year and +8.58% YTD, with dividends reinvested. Since Jun. 22, 2006, XPH is up +239.04% in real purchasing-power return, or +6.20%/yr, and is currently −21.07% below its real total-return high on Jul. 22, 2015.
Data ending Wed Oct. 7, 2026
| Thu 2006-06-22💬 to Wed 2026-10-07 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| XPH × |
+239.04%
+6.20%/yr |
+5.55%/yr
R2=0.547 |
||||
| SPDR S&P Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Thu 2006-06-22💬 to Wed 2026-10-07 |
Start
Value |
End
Value |
|---|---|---|
| XPH × |
$10,000.00
2006-06-22 |
$33,903.52
2026-10-07 |
| YTD | YoY | |
|---|---|---|
| XPH × | +8.58% | +26.33% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| XPH × |
−21.07%
on 2026-10-07 from 2015-07-22 peak |
−53.28%
on 2023-11-13 from 2015-07-22 peak |
| Period ending Wed 2026-10-07 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| XPH × | +26.33% |
+37.06% +17.07%/yr |
+52.47% +15.10%/yr |
+15.80% +2.98%/yr |
+12.73% +1.21%/yr |
| Year | XPH |
|---|---|
| 2026 (YTD) | +8.58% |
| 2025 | +28.18% |
| 2024 | +2.00% |
| 2023 | −0.37% |
| 2022 | −15.32% |
| 2021 | −16.42% |
| 2020 | +13.14% |
| 2019 | +22.81% |
| 2018 | −16.90% |
| 2017 | +9.73% |
| 2016 | −24.76% |
| 2015 | +0.92% |
| 2014 | +28.55% |
| 2013 | +58.46% |
| 2012 | +9.02% |
| 2011 | +9.48% |
| 2010 | +20.65% |
| 2009 | +24.28% |
| 2008 | −9.07% |
| 2007 | −4.91% |
| 2006 | +11.68% |
